Cell signaling and cancer
- PMID: 14522250
- DOI: 10.1016/s1535-6108(03)00216-2
Cell signaling and cancer
Abstract
During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. Many of the proteins currently under investigation as possible targets for cancer therapy are signaling proteins that are components of these pathways. The nature of these signaling pathways and their roles in tumorigenesis were the subject of a recent Beatson International Cancer Conference.
Similar articles
-
Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase.Eur J Cancer. 2000 Aug;36(13 Spec No):1595-606. doi: 10.1016/s0959-8049(00)00153-2. Eur J Cancer. 2000. PMID: 10959046 Review.
-
Signaling by integrin receptors.Oncogene. 1998 Sep 17;17(11 Reviews):1365-73. doi: 10.1038/sj.onc.1202172. Oncogene. 1998. PMID: 9779984 Review.
-
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements.J Virol. 2004 Apr;78(8):4207-23. doi: 10.1128/jvi.78.8.4207-4223.2004. J Virol. 2004. PMID: 15047836 Free PMC article.
-
Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival.Cancer Res. 2002 Oct 1;62(19):5590-6. Cancer Res. 2002. PMID: 12359772
-
The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation.Surgery. 2002 Aug;132(2):317-25. doi: 10.1067/msy.2002.125786. Surgery. 2002. PMID: 12219029
Cited by
-
Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion.FEBS Open Bio. 2021 Jun;11(6):1771-1784. doi: 10.1002/2211-5463.13173. Epub 2021 May 14. FEBS Open Bio. 2021. PMID: 33989451 Free PMC article.
-
Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice.Oncol Rep. 2020 Jan;43(1):169-176. doi: 10.3892/or.2019.7420. Epub 2019 Nov 28. Oncol Rep. 2020. PMID: 31789402 Free PMC article.
-
Towards an integrated systems-based modelling framework for drug transport and its effect on tumour cells.J Biol Eng. 2014 Jan 13;8:3. doi: 10.1186/1754-1611-8-3. eCollection 2014. J Biol Eng. 2014. PMID: 24764492 Free PMC article.
-
Pro-Tumoral Functions of Autophagy Receptors in the Modulation of Cancer Progression.Front Oncol. 2021 Feb 1;10:619727. doi: 10.3389/fonc.2020.619727. eCollection 2020. Front Oncol. 2021. PMID: 33634029 Free PMC article. Review.
-
The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms.J Mol Med (Berl). 2012 Jun;90(6):667-79. doi: 10.1007/s00109-011-0844-1. Epub 2012 Jan 4. J Mol Med (Berl). 2012. PMID: 22215152
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous